Cellular Oncology

Springer Nature

Journal websitePeer review: Peer review
Evaluation status available after sign-in

About the journal

Cellular Oncology is a journal published by Springer Nature in Netherlands. It is listed in MEDLINE according to the sources read. Declared publication charge: 4,190 EUR. Facts are reproduced as recorded at their sources with their capture dates; PublishLens indicators are available after sign-in.

Basic facts

Publisher
Springer Nature
ISSN
2211-3428 · 2211-3436
Country
Netherlands
Access
Not open access / not declared
Declared publication charge
4,190 EUR
Declared peer-review model
peer_review

Index listings

  • MEDLINE · 2010-01-01
Indexing
MEDLINE
APC
4,190 EUR
Declared review time (DOAJ)
—
Actual review time (measured)
122 days received→accepted — computed from PubMed (n=99)
Activity (OpenAlex)
Active — latest works 2026
PublishLens list status
Shown after sign-in
Counts for promotion at your university?
Choose your university and rank below ↓

Methodology signals (dated facts from their sources)

Details of the evaluation under the published methodology are shown to signed-in users (free).

Create a free account to view the evaluation

Journal profile

Descriptive metadata from public sources (DOAJ, OpenAlex, PubMed) as of the capture date shown — contains no assessment or judgment.

Works in OpenAlex

1202

Last recorded publication year

2026

Reported by OpenAlex in 1 of 3 sources (CC0 flags, not verified indexing)DOAJSciELOOpenAlex Core

h-index

74

i10-index

727

From OpenAlex open data (CC0).

Editorial & policy6
Observed digital preservation (Keepers registry)— snapshot 2026-10-05
CLOCKSSPortico
Editorial board
Official page ↗
Norwegian register (HK-dir)— 2026
Level 1 — approved scholarly channel
Open references deposited at Crossref
85%
ORCID iDs in current deposits
19%
Enrolled in Crossref Similarity Check
✓
Deposits licence metadata at Crossref
✓
Identity & continuity2
Source type
journal
NLM unique ID (PubMed)
101552938
Classification(no data)

No data available to the platform for this group

No platform data for: Classification — absence is not a judgment about the journal.

Subject areas

  • Cancer Cells and Metastasis
  • Cancer Cells and Metastasis
  • Cancer Cells and Metastasis
  • Cancer Immunotherapy and Biomarkers
  • Cancer-related molecular mechanisms research
  • Cancer, Hypoxia, and Metabolism
  • Ferroptosis and cancer prognosis
  • Cancer, Hypoxia, and Metabolism
Show all subjects (75)
  • Cancer, Hypoxia, and Metabolism
  • Cancer Immunotherapy and Biomarkers
  • Ferroptosis and cancer prognosis
  • Cancer Immunotherapy and Biomarkers
  • Immune cells in cancer
  • Immune cells in cancer
  • MicroRNA in disease regulation
  • Breast Cancer Treatment Studies
  • Epigenetics and DNA Methylation
  • Hepatocellular Carcinoma Treatment and Prognosis
  • MicroRNA in disease regulation
  • MicroRNA in disease regulation
  • Pancreatic and Hepatic Oncology Research
  • Epigenetics and DNA Methylation
  • Cancer-related molecular mechanisms research
  • Cancer-related molecular mechanisms research
  • Head and Neck Cancer Studies
  • Epigenetics and DNA Methylation
  • Glioma Diagnosis and Treatment
  • Cancer Genomics and Diagnostics
  • Cancer-related Molecular Pathways
  • Mechanisms of cancer metastasis
  • Immune cells in cancer
  • Gastric Cancer Management and Outcomes
  • Cancer, Lipids, and Metabolism
  • Colorectal Cancer Treatments and Studies
  • Ferroptosis and cancer prognosis
  • RNA modifications and cancer
  • Cancer-related Molecular Pathways
  • Cancer-related Molecular Pathways
  • Circular RNAs in diseases
  • Circular RNAs in diseases
  • Lung Cancer Treatments and Mutations
  • Immunotherapy and Immune Responses
  • Ubiquitin and proteasome pathways
  • RNA modifications and cancer
  • Lung Cancer Research Studies
  • Cancer Research and Treatments
  • Wnt/β-catenin signaling in development and cancer
  • TGF-β signaling in diseases
  • Immunotherapy and Immune Responses
  • RNA modifications and cancer
  • Wnt/β-catenin signaling in development and cancer
  • Cancer, Stress, Anesthesia, and Immune Response
  • Immunotherapy and Immune Responses
  • Cancer, Stress, Anesthesia, and Immune Response
  • Cancer Research and Treatments
  • Cancer, Lipids, and Metabolism
  • Cancer Genomics and Diagnostics
  • Cancer Genomics and Diagnostics
  • Glycosylation and Glycoproteins Research
  • Autophagy in Disease and Therapy
  • Glycosylation and Glycoproteins Research
  • Cancer, Lipids, and Metabolism
  • Autophagy in Disease and Therapy
  • Ubiquitin and proteasome pathways
  • Single-cell and spatial transcriptomics
  • Ubiquitin and proteasome pathways
  • Glioma Diagnosis and Treatment
  • Extracellular vesicles in disease
  • Single-cell and spatial transcriptomics
  • Extracellular vesicles in disease
  • Histone Deacetylase Inhibitors Research
  • Glioma Diagnosis and Treatment
  • Histone Deacetylase Inhibitors Research
  • Microtubule and mitosis dynamics
  • Microtubule and mitosis dynamics

Community confirmations — what users saw in MJL or Scopus Sources; not platform verification and never part of any score.

Loading community confirmations…
How do we evaluate?Publisher of this journal? Appeal a derived assessment or request a factual correction

The journal's record in other sources:Web of Science MJLDOAJ

Everything shown here is produced automatically from named sources (DOAJ, OpenAlex, Crossref, PubMed, the Norwegian register) as of its capture date, with no human editing. Facts appear as recorded at the source; derived scores (PCI, PTD, PublishLens score) follow a published methodology. Not a judgement on the journal, not an official accreditation, not advice.

Wrong items are corrected automatically by re-reading the source (24 h for daily sources, 7 days for weekly ones) with a dated change log, and each item links to its source record. PublishLens-derived assessments are contested through the appeals mechanism (15 working days). Appeals · Indicator guide

Norwegian register data: Kanalregisteret (HK-dir, Norway) — CC BY 4.0 / NLOD — adapted: level extracted per year · OASPA member list — CC BY

Last automated source read: